NEW YORK (GenomeWeb News) - Andrew Miller will step into the roles of senior VP and CFO at Cepheid in mid-April. Miller currently is VP and chief accounting officer at Autodesk, and before that he was senior VP and CFO at MarketFirst Software. Miller is taking over for John Sluis, who retired from Cepheid at the end of 2007.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.